Phase I Study of Gemcitabine and Liposomal Doxorubicin in Relapsed Ovarian Cancer

Publisher： Karger

E-ISSN： 1423-0232|62|2|110-114

ISSN： 0030-2414

Source： Oncology, Vol.62, Iss.2, 2002-03, pp. : 110-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Pegylated Liposomal Doxorubicin in Heavily Pretreated Epithelial Ovarian Cancer Patients

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 243-249

Karger

Access to resources Recommend Favorite

A Study of Pegylated Liposomal Doxorubicin in Platinum-Refractory Epithelial Ovarian Cancer

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 183-186

Karger

Access to resources Recommend Favorite

Carboplatin and Pegylated Liposomal Doxorubicin for Advanced Ovarian Cancer: Preliminary Activity Results of the MITO-2 Phase III Trial

By  

Oncology, Vol. 76, Iss. 1, 2008-11 ,pp. : 49-54

Karger

Access to resources Recommend Favorite

Phase I Study of Weekly Docetaxel and Liposomal Doxorubicin in Patients with Advanced Solid Tumors

By  

Oncology, Vol. 69, Iss. 3, 2005-10 ,pp. : 202-207

Karger

Access to resources Recommend Favorite

Liposomal doxorubicin in breast cancer

By Shehata M   Mukherjee A   Sharma R   Chan S  

Women's Health, Vol. 3, Iss. 5, 2007-09 ,pp. : 557-569

Future Medicine

Access to resources Recommend Favorite